Novel ABCC8 mutation in the genetic diagnosis of familial hyperinsulinaemic hypoglycaemia.
Deepthi KattamanchiPradeep Gejjegenahalli Channabasappa MaralusiddappaKrithika Manne VeerabhadraiahSharanabasavesh MangalgiPublished in: BMJ case reports (2024)
Familial hyperinsulinaemic hypoglycaemia-1 arises from mutations within the genes of pancreatic beta cells, resulting in unregulated insulin secretion from pancreatic beta cells. A 4.06 kg female neonate, born to a second-degree consanguineously married couple, presented with repeated asymptomatic hypoglycaemia. There was a significant history of a previous sibling's death from nesidioblastosis. Despite treatment with intravenous glucose, diazoxide, hydrochlorothiazide and octreotide, she continued to experience hypoglycaemic episodes. Despite efforts to manage sepsis, including antibiotics, antifungals and intravenous immunoglobulin/granulocyte-macrophage colony-stimulated factor, her condition worsened. She succumbed on day 34. This case underscores the complexities of managing congenital hyperinsulinaemic hypoglycaemia, especially in the context of concurrent infections and the need for multidisciplinary care. Early genetic diagnosis proved invaluable in facilitating timely and effective treatment. Furthermore, the genetic results enabled us to counsel the parents regarding the recurrence risk in subsequent pregnancies and the necessity for antenatal diagnosis.
Keyphrases
- type diabetes
- induced apoptosis
- genome wide
- cell cycle arrest
- healthcare
- high dose
- pregnant women
- gestational age
- squamous cell carcinoma
- preterm birth
- gene expression
- palliative care
- acute kidney injury
- intensive care unit
- peripheral blood
- radiation therapy
- signaling pathway
- free survival
- blood glucose
- transcription factor
- replacement therapy
- affordable care act